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Identity 
Other names: Alpha(B)-crystallin; CRYA2; CTPP2; 
HSPB5; HspB5 




Crystallins are a highly conserved protein family 
consisting of three classes, alpha, beta and gamma. The 
alpha crystallins are divided into two groups according 
to their acidic as well as basic character, namely A and 
B. The genes encoding the alpha crystallins A and B 
are located at chromosome 11 and 21, respectively. The 
hamster alpha-B crystallin (CRYAB) gene, which is 
highly homologous to that of humans, was cloned at 
first by Quax-Jeuken and it was demonstrated that te 
coding region of CRYAB consists of three exons 
(Quax-Jeuken et al., 1985). 
Transcription 
CRYAB was primarily found to be expressed in the 
lens. At the mRNA level Dubin and his group were th
first to detect CRYAB expression in several other 
tissues such as the lung, heart, skeletal muscle, kidney 
and to a lower extent within the brain and spleen 
(Dubin et al., 1989). 
Protein 
Description 
CRYAB encodes a 175 amino acid long protein with a 
molecular weight of 22kDa. Although the  
three-dimensional structure of CRYAB has not been 
resolved yet, the crystal structures of closely related 
other members of the heat shock protein family are 
available. This provided the assumption that CRYAB is 
composed of a highly conserved "alpha crystallin core" 
domain consisting of about 80 to 100 residues with a 
beta-sandwich structure (Ghosh et al., 2005). 
Expression 
CRYAB was initially found in the vertebrate lens. 
Iwaki and his group demonstrated CRYAB expression 
within heart, skeletal muscles, striated muscle, sciatic 
nerve, kidney and placenta by immunohistochemistry 
as well as immunoblotting and northern analyses 
(Iwaki et al., 1990). Further-more, CRYAB was found 
to be expressed in several human neoplasms. 
Localisation 
CRYAB exhibits mainly a cytosolic distribution. 
However, nuclear localisation with speckled intra-
nuclear formations in various types of unstressed cells 
was also reported (van den et al., 2003). 
Function 
CRYAB as well as alpha-A crystallin contribute to 
~35% of all vertebrate lens proteins. Therefore, it was 
firstly suggested that these proteins might be 
responsible for the refractory index of the eye andfor 
maintaining lens transparency. However, the high 
abundance of CRYAB in tissues other than the lens and 
its high homology to heat shock proteins suggested that 
CRYAB might also represent a small heat shock 
protein with the potential to exert molecular chaperon  
function. This suggestion was strengthened by 
Klemenz et al. by showing heat shock inducability of 
CRYAB on the promoter level (Klemenz et al., 1991). 
Basing on the potential of heat shock proteins to bind to  
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unfolded and denatured proteins, thus maintaining a 
less non-specific protein aggregation, a potential role of 
CRYAB in inclusion body formation in the course of 
several neurodegenerative diseases such as Alexander 
disease (Iwaki et al., 1993), Alzheimer's disease 
(Shinohara et al., 1993), Creutzfeldt-Jacob disease 
(Kato et al., 1992) and Parkinson's disease (Iwaki et al., 
1992) has been suggested. Further-more CRYAB was 
found to serve as an auto-antigen in multiple sclerosis 
(van Noort et al., 1995) and it was shown that small 
heat shock proteins such as CRYAB are involved in the 
promotion of prolonged survival of cancer cells by 
inhibiting apoptosis (Kamradt et al., 2001). 
Homology 
CRYAB exhibits a high homology of 56% to alpha-A-
crystallin. Moreover, additional homologies to several 




Until now, there are two known mutations within the 
CRYAB gene with potential impact on human 
pathologies. Vicart and his group found a missense 
mutation of R120G within the CRYAB gene, which 
was associated with desmin-related myopathy (Vicart 
et al., 1998). Furthermore a deletion muta-tion within 
exon 3, 450delA, which results in an aberrant protein, 
was found to be related to dominant posterior 




It was reported that CRYAB expression is strongly 
associated with lymph node metastasis in breast cancer 
(Chelouche-Lev et al., 2004). This result was further 
supported by the high abundance of CRYAB in basal 
like breast carcinoma, which represents a subgroup of 
breast cancers with bad prognosis and high metastatic 
potential (Moyano et al., 2006). Furthermore, this 
research group demonstrated activation of the 
MEK/ERK pathway through CRYAB over-expression 
in immortalized human mammary epithelial cells, 
which lead to increased cell migration and invasion. 
This effect could be entirely suppressed using 
MEK/ERK inhibitors. 
Renal cell carcinoma 
Note 
Up-regulation of CRYAB expression was found in 
cultured renal cell carcinoma cells as well as in  
tissues derived from renal cell carcinomas (Shi et al., 
2004). This finding was further confirmed by another 
research group using protein chip and 




Expression of CRYAB within malignant brain tumours 
such as astrocytomas, oligodendrogliomas and 
glioblastoma multiforme (GBM) was reported (Iwaki et 
al., 1991; Aoyama et al., 1993; Shinohara et al., 1993). 
Moreover, it was demonstrated that chemotherapy 
induces an increased expression of CRYAB in 
neuroblastomas (Ishiguro et al., 1997). Comparative 
proteomic studies on human low grade astrocytomas 
and GBM showed a significant higher expression of 
CRYAB within the GBM (Odreman et al., 2005). 
Anaplastic thyroid carcinoma 
Note 
Mineva showed differential regulation of CRYAB and 
the closely related heat shock protein 27-1 (HSP27-1) 
within the highly malignant anaplastic thyroid 
carcinomas (ATC). Whereas CRYAB expression was 
found to be down-regulated, HSP27-1 was 
considerably expressed within ATC (Mineva et al., 
2005). Analyses of the CRYAB promotor region 
including tumor associated methylation analysis as well 
as CRYAB promoter specific trasncription factor 
analysis lead to the suggestion that this might be due to 
tumor specific transcription factor and promoter 
methylation patterns. 
Buccal squamous carcinoma 
Note 
This type of carcinoma, which is mostly seen in central 
and southeast Asia, is characterized by a considerably 
aggressive course. Chen and his group performed a 
proteomic assay in order to define the expression 
pattern of cancer-related proteins within this tumor 
entity. Similar to the anaplastic thyroid carcinomas, 
CRYAB was found to be under-represented, whereas 
several other proteins involved in heat shock respon es 
and anti-oxidative processes were up-regulated (Chen 
et al., 2004). 
Head and neck cancer 
Note 
In consistence with findings of breast cancer research, a 
high extent of CRYAB expression was found to be a 
strong predictive marker for short survival rates of 
patients suffering from head and neck cancer (Chin et 
al., 2005). However, an investigation of head and neck 
squamous cell carcinoma did not reveal a significant 
association between patient survival and CRYAB 
expression (Boslooper et al., 2008). 
Hepatocellular carcinoma 
Note 
The CRYAB gene was found to be highly expressed in 
a subgroup of hepatocellular carcinomas, which was 
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associated with declined survival rates (Tang et al., 
2009). It was suggested that CRYAB might serve as a
prognostic marker within hepatocellular carcinomas. 
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